Skip to main content
SpringerLink
Log in

Ethnic Variations in Adiponectin Levels and Its Association with Age, Gender, Body Composition and Diet: Differences Between Iranians, Indians and Europeans Living in Australia

  • Original Paper
  • Published:
Journal of Immigrant and Minority Health Aims and scope Submit manuscript

Abstract

Adiponectin is an adipocyte-derived protein with anti-diabetic, anti-atherogenic and anti-inflammatory action, but there are few studies on its association with cardiovascular and metabolic risk factors in different ethnic groups in Australia. This cross-sectional study evaluated ethnic differences in adiponectin levels and its association with age, gender, body composition and diet in 89 adult Australians of European (n = 28), Indian (n = 28) and Iranian (n = 33) ancestries. Different measures of adiposity were assessed using the method of whole body dual energy X-ray absorptiometry (DEXA). Total adiponectin levels determined in Indians and Iranians were significantly lower than those in Europeans (p values < 0.001). There was no significant difference between the adiponectin levels in Indians and Iranians (p value > 0.05). There was no substantial change in the results after adjustment for potential confounders. Circulating levels of adiponectin was associated with age, truncal fat percentage, dietary glycemic index, glycemic load and carbohydrate intake, by correlation analysis (p values < 0.05). Using multiple linear regression analysis, a model including truncal fat percentage (p < 0.001), ethnicity (p = 0.001), age (p = 0.001) and dietary glycemic index (p = 0.04) could predict 50% of the variance in adiponectin levels (R2 = 0.504). Among different variables assessed, truncal fat percentage (in Indian and Iranian groups) and glycemic index (in European group) were the strongest predictors of serum adiponectin when data were analysed for three ethnic groups, separately. In conclusion, individuals with Iranian or Indian ancestries may have lower adiponectin levels compared to Europeans. Ethnicity was found as an independent factor affecting adiponectin levels. Our results also highlighted age, truncal adiposity and dietary glycemic index as other determinants of serum adiponectin, however the extent to which these factors influence adiponectin concentrations may vary across ethnicities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 2004;53(Suppl 1):S143–51.

    CAS  PubMed  Google Scholar 

  2. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care. 2003;26(8):2442–50.

    CAS  PubMed  Google Scholar 

  3. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257(1):79–83.

    CAS  PubMed  Google Scholar 

  4. Achari AE, Jain SK. Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction. Int J Mol Sci. 2017;18(6):1321.

    PubMed Central  Google Scholar 

  5. Balsan GA, Vieira JL, Oliveira AM, Portal VL. Relationship between adiponectin, obesity and insulin resistance. Revista da Associacao Medica Brasileira. 2015;61(1):72–80.

    PubMed  Google Scholar 

  6. Gable DR, Hurel SJ, Humphries SE. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis 2006;188(2):231–44.

    CAS  PubMed  Google Scholar 

  7. Snehalatha C, Mukesh B, Simon M, Viswanathan V, Haffner SM, Ramachandran A. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians. Diabetes Care. 2003;26(12):3226–9.

    PubMed  Google Scholar 

  8. Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study. Diabetes Care. 2003;26(7):2015–20.

    CAS  PubMed  Google Scholar 

  9. Efstathiou SP, Tsioulos DI, Tsiakou AG, Gratsias YE, Pefanis AV, Mountokalakis TD. Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke 2005;36(9):1915–9.

    CAS  PubMed  Google Scholar 

  10. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004;291(14):1730–7.

    CAS  PubMed  Google Scholar 

  11. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86(5):1930–5.

    CAS  PubMed  Google Scholar 

  12. Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci. 2002;103(2):137–42.

    CAS  PubMed  Google Scholar 

  13. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003;361(9353):226–8.

    CAS  PubMed  Google Scholar 

  14. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002;360(9326):57–8.

    CAS  PubMed  Google Scholar 

  15. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26(3):439–51.

    CAS  PubMed  Google Scholar 

  16. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Investig. 2006;116(7):1784–92.

    CAS  PubMed  Google Scholar 

  17. Henneman P, Aulchenko YS, Frants RR, Zorkoltseva IV, Zillikens MC, Frolich M, et al. Genetic architecture of plasma adiponectin overlaps with the genetics of metabolic syndrome-related traits. Diabetes Care. 2010;33(4):908–13.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Ling H, Waterworth DM, Stirnadel HA, Pollin TI, Barter PJ, Kesaniemi YA, et al. Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study. Obesity 2009;17(4):737–44.

    CAS  PubMed  Google Scholar 

  19. Jee SH, Sull JW, Lee JE, Shin C, Park J, Kimm H, et al. Adiponectin concentrations: a genome-wide association study. Am J Hum Genet. 2010;87(4):545–52.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Gonzalez-Sanchez JL, Zabena CA, Martinez-Larrad MT, Fernandez-Perez C, Perez-Barba M, Laakso M, et al. An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance. Obes. Res. 2005;13(5):807–12.

    CAS  PubMed  Google Scholar 

  21. Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Hussain T. Adiponectin gene variants and the risk of coronary artery disease in patients with type 2 diabetes. Mol Biol Rep. 2011;38(6):3703–8.

    CAS  PubMed  Google Scholar 

  22. Prakash J, Mittal B, Awasthi S, Srivastava N. Association of adiponectin gene polymorphism with adiponectin levels and risk for insulin resistance syndrome. Int J Prev Med. 2015;6:31.

    PubMed  PubMed Central  Google Scholar 

  23. Sabouri S, Ghayour-Mobarhan M, Moohebati M, Hassani M, Kassaeian J, Tatari F, et al. Association between 45T/G polymorphism of adiponectin gene and coronary artery disease in an Iranian population. Sci World J. 2011;11:93–101.

    Google Scholar 

  24. Mohammadzadeh G, Ghaffari MA, Heibar H, Bazyar M. Association of two common single nucleotide polymorphisms (+ 45T/G and + 276G/T) of ADIPOQ gene with coronary artery disease in type 2 diabetic patients. Iran Biomed J. 2016;20(3):152–60.

    PubMed  PubMed Central  Google Scholar 

  25. Yao M, Wu Y, Fang Q, Sun L, Li T, Qiao H. Association of ADIPOQ variants with type 2 diabetes mellitus susceptibility in ethnic Han Chinese from northeast China. J Diabetes Investig. 2016;7(6):853–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Reis CE, Bressan J, Alfenas RC. Effect of the diet components on adiponectin levels. Nutr Hosp. 2010;25(6):881–8.

    CAS  PubMed  Google Scholar 

  27. Makhdoumi P, Zarif-Yeganeh M, Hedayati M. Physical Activity and Obesity Related Hormones. Zahedan J Res Med Sci. 2014;16(8):6–11.

    Google Scholar 

  28. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003;289(14):1799–804.

    CAS  PubMed  Google Scholar 

  29. Yannakoulia M, Yiannakouris N, Melistas L, Kontogianni MD, Malagaris I, Mantzoros CS. A dietary pattern characterized by high consumption of whole-grain cereals and low-fat dairy products and low consumption of refined cereals is positively associated with plasma adiponectin levels in healthy women. Metabolism 2008;57(6):824–30.

    CAS  PubMed  Google Scholar 

  30. Rokling-Andersen MH, Reseland JE, Veierod MB, Anderssen SA, Jacobs DR Jr, Urdal P, et al. Effects of long-term exercise and diet intervention on plasma adipokine concentrations. Am J Clin Nutr. 2007;86(5):1293–301.

    CAS  PubMed  Google Scholar 

  31. Hulver MW, Zheng D, Tanner CJ, Houmard JA, Kraus WE, Slentz CA, et al. Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab. 2002;283(4):E861–5.

    CAS  PubMed  Google Scholar 

  32. Yeung EH, Appel LJ, Miller ER 3rd, Kao WH. The effects of macronutrient intake on total and high-molecular weight adiponectin: results from the OMNI-Heart trial. Obesity 2010;18(8):1632–7.

    CAS  PubMed  Google Scholar 

  33. Hanley AJ, Connelly PW, Harris SB, Zinman B. Adiponectin in a native Canadian population experiencing rapid epidemiological transition. Diabetes Care. 2003;26(12):3219–25.

    PubMed  Google Scholar 

  34. Hulver MW, Saleh O, MacDonald KG, Pories WJ, Barakat HA. Ethnic differences in adiponectin levels. Metabolism 2004;53(1):1–3.

    CAS  PubMed  Google Scholar 

  35. Mente A, Razak F, Blankenberg S, Vuksan V, Davis AD, Miller R, et al. Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care. 2010;33(7):1629–34.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Hanley AJ, Bowden D, Wagenknecht LE, Balasubramanyam A, Langfeld C, Saad MF, et al. Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans. J Clin Endocrinol Metab. 2007;92(7):2665–71.

    CAS  PubMed  Google Scholar 

  37. Meilleur KG, Doumatey A, Huang H, Charles B, Chen G, Zhou J, et al. Circulating adiponectin is associated with obesity and serum lipids in West Africans. J Clin Endocrinol Metab. 2010;95(7):3517–21.

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Khoo CM, Sairazi S, Taslim S, Gardner D, Wu Y, Lee J, et al. Ethnicity modifies the relationships of insulin resistance, inflammation, and adiponectin with obesity in a multiethnic Asian population. Diabetes Care. 2011;34(5):1120–6.

    PubMed  PubMed Central  Google Scholar 

  39. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999;100(25):2473–6.

    CAS  PubMed  Google Scholar 

  40. Kaplan GA, Keil JE. Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation 1993;88(4):1973–98.

    CAS  PubMed  Google Scholar 

  41. Davis SK, Xu R, Riestra P, Gebreab SY, Khan RJ, Gaye A, et al. Association of adiponectin and socioeconomic status in African American men and women: the Jackson heart study. BMC Public Health. 2016;16:511.

    PubMed  PubMed Central  Google Scholar 

  42. Atkinson FS, Foster-Powell K, Brand-Miller JC. International tables of glycemic index and glycemic load values: 2008. Diabetes Care. 2008;31(12):2281–3.

    PubMed  PubMed Central  Google Scholar 

  43. Liu C, Bai Y, Xu X, Sun L, Wang A, Wang T-Y, et al. Exaggerated effects of particulate matter air pollution in genetic type II diabetes mellitus. Part Fibre Toxicol. 2014;11(1):27.

    PubMed  PubMed Central  Google Scholar 

  44. Giles GG, Ireland P. Dietary questionnaire for epidemiological studies (version 2). Melbourne: The Cancer Council Victoria; 1996.

    Google Scholar 

  45. Hodge A, Patterson A, Brown W, Ireland P, Giles G. The Anti Cancer Council of Victoria FFQ: relative validity of nutrient intakes compared with weighed food records in young to middle-aged women in a study of iron supplementation. Aust N Z J Public Health. 2000;24(6):576–83.

    CAS  PubMed  Google Scholar 

  46. Cancer Council Victoria. Dietary Questionnaires, DQES v2; 2008. http://www.cancervic.org.au/research/epidemiology/nutritional_assessment_services1.

  47. Craig C, Marshall A, Sjöström M, Bauman A, Booth M, Ainsworth B, et al. and the IPAQ Consensus Group and the IPAQ Reliability and Validity Study Group. International Physical Activity Questionnaire (IPAQ): 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–95.

    PubMed  Google Scholar 

  48. Jeyaseelan L, Rao PS. Methods of determining sample sizes in clinical trials. Indian Pediatr. 1989;26(2):115–21.

    CAS  PubMed  Google Scholar 

  49. Shojaie M, Sotoodah A, Shafaie G. Is adiponectin associated with acute myocardial infarction in Iranian non obese patients? Lipids Health Dis. 2009;8:17.

    PubMed  PubMed Central  Google Scholar 

  50. Pischon T, Girman CJ, Rifai N, Hotamisligil GS, Rimm EB. Association between dietary factors and plasma adiponectin concentrations in men. Am J Clin Nutr. 2005;81(4):780–6.

    CAS  PubMed  Google Scholar 

  51. Shibata R, Ouchi N, Murohara T. Adiponectin and cardiovascular disease. Circ J. 2009;73(4):608–14.

    CAS  PubMed  Google Scholar 

  52. Lai H, Lin N, Xing Z, Weng H, Zhang H. Association between the level of circulating adiponectin and prediabetes: a meta-analysis. J Diabetes Investig. 2015;6(4):416–29.

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Nakamura Y, Shimada K, Fukuda D, Shimada Y, Ehara S, Hirose M, et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 2004;90(5):528–33.

    CAS  PubMed  PubMed Central  Google Scholar 

  54. Gruzdeva O, Uchasova E, Belik E, Dyleva Y, Shurygina E, Barbarash O. Lipid, adipokine and ghrelin levels in myocardial infarction patients with insulin resistance. BMC Cardiovasc Disord. 2014;14:7.

    PubMed  PubMed Central  Google Scholar 

  55. Mohammadzadeh G, Zarghami N. Associations between single-nucleotide polymorphisms of the adiponectin gene, serum adiponectin levels and increased risk of type 2 diabetes mellitus in Iranian obese individuals. Scand J Clin Lab Investig. 2009;69(7):764–71.

    CAS  Google Scholar 

  56. Smith J, Al-Amri M, Sniderman A, Cianflone K. Leptin and adiponectin in relation to body fat percentage, waist to hip ratio and the apoB/apoA1 ratio in Asian Indian and Caucasian men and women. Nutr Metab. 2006;3:18.

    Google Scholar 

  57. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler thromb Vascu Biol. 2004;24(1):29–33.

    CAS  Google Scholar 

  58. Qi L, Rimm E, Liu S, Rifai N, Hu FB. Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men. Diabetes Care. 2005;28(5):1022–8.

    CAS  PubMed  Google Scholar 

  59. Loh BI, Sathyasuryan DR, Mohamed HJ. Plasma adiponectin concentrations are associated with dietary glycemic index in Malaysian patients with type 2 diabetes. Asia Pac J Clin Nutr. 2013;22(2):241–8.

    CAS  PubMed  Google Scholar 

  60. Staiger H, Tschritter O, Machann J, Thamer C, Fritsche A, Maerker E, et al. Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obesity Res. 2003;11(3):368–72.

    CAS  Google Scholar 

  61. Simpson KA, Singh MA. Effects of exercise on adiponectin: a systematic review. Obesity 2008;16(2):241–56.

    CAS  PubMed  Google Scholar 

  62. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation 1999;99(9):1165–72.

    CAS  PubMed  Google Scholar 

  63. Obata Y, Yamada Y, Takahi Y, Baden MY, Saisho K, Tamba S, et al. Relationship between serum adiponectin levels and age in healthy subjects and patients with type 2 diabetes. Clin Endocr. 2013;79(2):204–10.

    CAS  PubMed  Google Scholar 

  64. Schautz B, Later W, Heller M, Peters A, Muller MJ, Bosy-Westphal A. Impact of age on leptin and adiponectin independent of adiposity. Br J Nutr. 2012;108(2):363–70.

    CAS  PubMed  Google Scholar 

  65. Mallamaci F, Zoccali C, Cuzzola F, Tripepi G, Cutrupi S, Parlongo S, et al. Adiponectin in essential hypertension. J Nephrol. 2002;15(5):507–11.

    CAS  PubMed  Google Scholar 

  66. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 2002;13(1):134–41.

    CAS  PubMed  Google Scholar 

  67. Isobe T, Saitoh S, Takagi S, Takeuchi H, Chiba Y, Katoh N, et al. Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study. Eur J Endocrinol. 2005;153(1):91–8.

    CAS  PubMed  Google Scholar 

  68. Koh SJ, Hyun YJ, Choi SY, Chae JS, Kim JY, Park S, et al. Influence of age and visceral fat area on plasma adiponectin concentrations in women with normal glucose tolerance. Clin Chim Acta. 2008;389(1–2):45–50.

    CAS  PubMed  Google Scholar 

  69. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003;46(4):459–69.

    CAS  PubMed  Google Scholar 

  70. Combs TP, Berg AH, Rajala MW, Klebanov S, Iyengar P, Jimenez-Chillaron JC, et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 2003;52(2):268–76.

    CAS  PubMed  Google Scholar 

  71. Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J, et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem. 2005;280(18):18073–80.

    CAS  PubMed  Google Scholar 

  72. Arner P. Site differences in human subcutaneous adipose tissue metabolism in obesity. Aesthet Plast Surg. 1984;8(1):13–7.

    CAS  Google Scholar 

  73. Bastard J-P, Bruno F. Physiology and physiopathology of adipose tissue. Paris: Springer; 2012.

    Google Scholar 

  74. Perrini S, Laviola L, Cignarelli A, Melchiorre M, De Stefano F, Caccioppoli C, et al. Fat depot-related differences in gene expression, adiponectin secretion, and insulin action and signalling in human adipocytes differentiated in vitro from precursor stromal cells. Diabetologia 2008;51(1):155–64.

    CAS  PubMed  Google Scholar 

  75. Ferreira I, Snijder MB, Twisk JW, van Mechelen W, Kemper HC, Seidell JC, et al. Central fat mass versus peripheral fat and lean mass: opposite (adverse versus favorable) associations with arterial stiffness? The Amsterdam Growth and Health Longitudinal Study. J Clin Endocrinol Metab. 2004;89(6):2632–9.

    CAS  PubMed  Google Scholar 

  76. Chandalia M, Lin P, Seenivasan T, Livingston EH, Snell PG, Grundy SM, et al. Insulin resistance and body fat distribution in South Asian men compared to Caucasian men. PLoS ONE. 2007;2(8):e812.

    PubMed  PubMed Central  Google Scholar 

  77. Bjorndal B, Burri L, Staalesen V, Skorve J, Berge RK. Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. J Obesity. 2011;2011:490650.

    Google Scholar 

  78. Meshkini M, Alaei-Shahmiri F, Mamotte C, Earnest J. Ethnic variation in lipid profile and its associations with body composition and diet: differences between Iranians, Indians and Caucasians living in Australia. J Immigr Minor Health. 2016;19:67–73

    Google Scholar 

  79. Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM, et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr. 1981;34(3):362–6.

    CAS  PubMed  Google Scholar 

  80. Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr. 2002;76(1):5–56.

    CAS  PubMed  Google Scholar 

  81. McKeown NM, Meigs JB, Liu S, Saltzman E, Wilson PW, Jacques PF. Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort. Diabetes Care. 2004;27(2):538–46.

    PubMed  Google Scholar 

  82. Liu S, Willett WC, Stampfer MJ, Hu FB, Franz M, Sampson L, et al. A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr. 2000;71(6):1455–61.

    CAS  PubMed  Google Scholar 

  83. Yang WS, Chen MH, Lee WJ, Lee KC, Chao CL, Huang KC, et al. Adiponectin mRNA levels in the abdominal adipose depots of nondiabetic women. Int J Obes Relat Metab Disord. 2003;27(8):896–900.

    CAS  PubMed  Google Scholar 

  84. Mine Y, Miyashita K, Shahidi F, editors. Nutrigenomics and proteomics in health and disease: food factors and gene interactions. New York: Wiley; 2009.

    Google Scholar 

  85. Brand-Miller JC, Holt SH, Pawlak DB, McMillan J. Glycemic index and obesity. Am J Clin Nutr. 2002;76(1):281S–5S.

    CAS  PubMed  Google Scholar 

  86. Morakinyo AO, Samuel TA, Adekunbi DA, Adegoke OA. Niacin improves adiponectin secretion, glucose tolerance and insulin sensitivity in diet-induced obese rats. Egypt J Basic Appl Sci. 2015;2(4):261–7.

    Google Scholar 

  87. Soheilykhah S, Dehestani MR, Mohammadi SM, Afkhami-Ardekani M, Eghbali SA, Dehghan F. The effect of zinc supplementation on serum adiponectin concentration and insulin resistance in first degree relatives of diabetic patients. Iran J Diabetes Obesity. 2012;4(2):57–62.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. International Health Program, Curtin University, Perth, WA, 6102, Australia

    Majid Meshkini & Jaya Dantas

  2. Department of Epidemiology, School of Public Health, Iran University of Medical Sciences (IUMS), Tehran, Iran

    Majid Meshkini

  3. Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences (IUMS), Tehran, Iran

    Fariba Alaei-Shahmiri

  4. School of Biomedical Sciences and Curtin Health Innovation Research Institute, Curtin University, Perth, WA, 6102, Australia

    Cyril Mamotte

Authors
  1. Majid Meshkini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fariba Alaei-Shahmiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cyril Mamotte
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jaya Dantas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fariba Alaei-Shahmiri.

Ethics declarations

Conflict of interest

Majid Meshkini, Fariba Alaei-Shahmiri, Cyril Mamotte and Jaya Dantas declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Meshkini, M., Alaei-Shahmiri, F., Mamotte, C. et al. Ethnic Variations in Adiponectin Levels and Its Association with Age, Gender, Body Composition and Diet: Differences Between Iranians, Indians and Europeans Living in Australia. J Immigrant Minority Health 20, 1362–1372 (2018). https://doi.org/10.1007/s10903-018-0706-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10903-018-0706-9

Keywords

Search

Navigation